ICYMI: Top Content From Kidney Week 2022 – Managed Markets Network

Kidney Week 2022 focused on effectiveness of treatment for chronic kidney disease, health misinformation, and outcomes in chronic kidney disease, among other topics.
Kidney Week 2022, which took place in Orlando, Florida, from November 1 to November 6, focused on multiple topics within nephrology care. Chronic kidney disease (CKD) outcomes and treatment were 2 of the topics covered during the conference, and experts in the field also touched on the role of the medical community in disproving health misinformation.

Here was the top content published from Kidney Week 2022.

Empagliflozin Cuts Risk of Cardiovascular Death, More Severe CKD by 28%, Study Finds

A 28% reduction in the risk of progressing or dying from cardiovascular issues was found in patients with CKD when they were treated with empagliflozin, a sodium-glucose co-transporter-2 inhibitor. The EMPA-KIDNEY study was first designed to test the efficacy of empagliflozin in patients with CKD who had various symptoms, including those with decreased kidney function and those with increased albuminuria. The study found that more patients in the placebo group had progression of kidney disease or death from cardiovascular disease compared with patients using empagliflozin (16.9% vs 13.1%) in 2 years of follow-up.

Dr Jen Gunter Addresses the Evolving Role of the Medical Community in Combating Health Misinformation

Jen Gunter, MD, spoke with us about the new role that the medical and scientific communities have in disproving and clarifying health care misinformation found on social media and in the press. Gunter said that physicians have been more open about speaking to the press and the public about disinformation than they had been prior to the COVID-19 pandemic. She said that some doctors and physicians with more job security are more apt to speak out on their opinions than new doctors or doctors employed by certain medical institutions. Making it easy and safe for doctors to speak out is something to strive for, according to Gunter.

CKD Outcomes Improve for Black Adults When DASH Diet Is Combined With Coaching, Assistance

A Dietary Approaches to Stop Hypertension (DASH) diet was able to improve outcomes for CKD in Black adults when combined with coaching and assistance, according to a study presented at the conference. Lack of access to healthy food could lead to higher rates of hypertension and advanced CKD in Black adults who live in the United States. The DASH diet promoted a heart-healthy diet that was rich in potassium and low in sodium. The study found that patients who had dietician-directed coaching had a 73.3% decrease in urine albuminin-to-creatinine ratio whereas the self-directed group had a 20.5% increase.

Dr Jennifer Green Discusses Positive Efficacy of Empagliflozin Among Patients With CKD in the EMPA-KIDNEY Trial
Jennifer Green, MD, spoke with us about the results of the EMPA-KIDNEY trial, which found that patients with CKD treated with empagliflozin had a 28% reduced risk of mortality from cardiovascular disease or progression of CKD. Green said that the trial included various patients with CKD both with and without diabetes and with CKD of different types. She also said that the results were consistent across many subgroups. At-risk individuals can now look forward to these therapies for treatment.
FDA Approves Bispecific Antibody Mosunetuzumab for R/R Follicular Lymphoma
The approval makes mosunetuzumab the first in its class approved to treat follicular lymphoma and comes shortly after data from a phase 2 trial was presented at the annual meeting of the American Society of Hematology.
Read More
High-Deductible Health Plans and Their Potential Impact on the US Drug Epidemic
On this episode of Managed Care Cast, we speak with Matthew D. Eisenberg, PhD, lead author of a study published in the October issue of The American Journal of Managed Care® that investigated the use of high-deductible health plans and their impact on substance use disorder care and spending.
Read More
Top 5 Most-Read SAP Content of 2022
The most-read articles related to our Strategic Alliance Partnership (SAP) program focused on behavioral health, oncology care, and partner news.
Read More
The Importance of Tailored Care Management Programs for High-risk Patients
On this episode of Managed Care Cast, we speak with 2 authors of an article in the September issue of The American Journal of Managed Care®, which focused on the results of their evaluation of an intensive, community-based care management program for dual-eligible Medicaid ACO high-risk patients.
Read More
Top 5 Most-Read Rare Disease Articles of 2022
The most-read rare disease articles of the year included the topics of new pediatric central nervous system tumor guidelines, graft versus host disease, the contribution of gene variants to pediatric neuropsychiatric conditions, and hope for patients with blast-phase chronic myeloid leukemia.
Read More
Top 5 Most-Read Hemophilia Articles of 2022
The most-read hemophilia articles of the year highlighted new drug developments for hemophilia, the impact of carrier status, and opportunities for better patient education.
Read More
2 Clarke Drive
Cranbury, NJ 08512


Related Articles

Leave a Reply

Your email address will not be published. Required fields are marked *

Back to top button